CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	6 Months Ended
	Jun. 30, 2011	Jun. 30, 2010
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (750,000)	$ (505,000)
Adjustments to reconcile net loss to net cash used in operating activities:
Common stock issued for services	240,000
Stock based compensation related to vesting of stock warrants		68,000
Depreciation and amortization	30,000	17,000
Changes in operating assets and liabilities:
Prepaid expenses and other assets	(64,000)	53,000
Unbilled revenue		(43,000)
Accounts payable and accrued expenses	16,000	40,000
Accrued interest and expenses-related parties	25,000	70,000
Deferred revenue	171,000
Net cash used in operating activities;	(332,000)	(300,000)
CASH FLOWS FROM INVESTING ACTIVITIES:
Net cash provided by investing activities
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock, net of offering costs		216,000
Net cash provided by financing activities		216,000
NET DECREASE IN CASH AND CASH EQUIVALENTS	(332,000)	(84,000)
Cash and cash equivalents, beginning of period	1,055,000	362,000
CASH AND CASH EQUIVALENTS, END OF PERIOD	723,000	278,000
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Interest paid
Income taxes paid
Non-cash investing activities:
14,000,000 shares of common stock issued for acquisition of Scientific Nanomedicine, Inc.	840,000
1,000 shares of common stock issued for the acquisition of Senior Scientific, LLC	$ 60,000